The Stanford researchers developed a surgical strike to replace the nuke. They used an antibody called anti-CD117 to target ...
Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced that it will present ...
A Stanford study confirmed a complete reversal of type 1 diabetes in mice through a combination of stem cell transplants and ...
A Brazilian woman is discovered to be a human 'chimera'. She carries her twin brother's DNA in her blood cells, making her ...
HemeNext 2025, held at The Westin Hotel, Gurgaon on the 22nd and 23rd of November, welcomed nearly 300 delegates from across the country, making it one of India's most anticipated gatherings in the ...
Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in ...
Johnson & Johnson stock rises on strong earnings, the Halda deal, FDA wins and an upcoming orthopedics spinoff as analysts weigh the outlook.
Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis ...
The Brighterside of News on MSN
Stanford researchers cure type 1 diabetes in mice by resetting the body's immune system
A team at Stanford Medicine has delivered something people with Type 1 diabetes have waited decades to hear: a cure in ...
Hidden Guests” explores how the emerging field of microchimerism is upending medicine, genetics, and our sense of self.
Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback